May 29 |
Agenus: Multiple Milestones In The Second Half Of 2024
|
May 24 |
Agenus gains after updating early-stage cancer drug data
|
May 23 |
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
|
May 23 |
Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
|
May 22 |
3 Magnificent Growth Stocks to Buy Hand Over Fist
|
May 16 |
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
|
May 8 |
Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript
|
May 8 |
Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
May 8 |
Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
|
May 7 |
Agenus (AGEN) Q1 2024 Earnings Call Transcript
|